Abstract:Background Diabetic cardiovascular complication is a major cause of mortality in type 2 diabetic patients. Hyperglycemia markedly increases the risk of cardiovascular disease. Endothelial dysfunction is common in type 2 diabetes mellitus (DM) and is an early indicator of diabetic vascular disease. Therefore, it is necessary to identify the effect of different hypoglycemic agents on vascular endothelium. The aim of the study was to examine and compare the effects of metformin and gliquidone on atherosclerotic lesions in streptozotocin-induced diabetic rats. Methods Forty male Sprague-Dawley rats (age, 8 weeks; weight, 180–200 g) were included in this study and fed with a normal chow diet for 1 week. Rats (n=10) served as the normal control group (NC group) were fed with a normal chow for another 2 weeks and received an injection of saline. The rest 30 rats fed with a high-fat diet for 2 weeks and injected streptozotocin were randomly assigned to three groups (n=10 rats per group) as follow: type 2 DM group (DM group), DM + gliquidone group (GLI group) and DM + metformin group (MET group). Five weeks later, all rats were fasted overnight and taken tail blood samples for biochemical determinations. Then rats in the NC and DM groups were administrated with normal saline, while rats in the MET and GLI groups were administrated with metformin (100 mg/kg) or gliquidone (10 mg/kg), respectively. All medicines were given via intragastric administration for 8 weeks. After 16 weeks, plasma triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) were measured. The aortic arch was isolated from diabetic rats and was assessed by pathological sectioning using H&E staining. Results Metformin treatment prevented weight gain ((315.80±52.16) g vs. (318.70±68.48) g, P=0.773), improved plasma TG, HDL-C and LDL-C levels (P=0.006, 0.003, 0.001, respectively, all P <0.05). However, gliquidone showed no significant effects on plasma TG and TC levels (P=0.819, 0.053, respectively). LDL-C and HDL-C in the GLI group changed ((0.46±0.10) mmol/L vs. (0.36±0.14) mmol/L, P=0.007; (0.99±0.27) mmol/L vs. (1.11±0.18) mmol/L, P=0.049). Both metformin and gliquidone treatment lowered blood glucose levels (P=0.001, 0.004, respectively, P <0.05). Under light microscopy, no changes were observed in the aortic wall structure of each layer; the intima was smooth and the membrane elastic fibers were normal in the NC group. In the DM group, the aortic wall structure was unclear, the intima was thickened with irregular intima, and membrane elastic fibers collapsed. The aortic intima in the MET and GLI groups was smoother compared with the DM group, but the endothelial structure of the MET group was closer to that of the NC group. Conclusions Both metformin and gliquidone have anti-atherosclerotic effects. But the endothelial structure of the MET group was closer to that of the NC group. Metformin and gliquidone therapy can reduce serum level of LDL-C and increase level of HDL-C, whereas gliquidone therapy did not lose weight and decrease serum level of TG. These data may have important implications for the treatment of patients with type 2 DM.

The Effects of LMWH and Clopidogrel on Plasma Hypercoagulation State in Type 2 Diabetic Patients

Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study.

[Effects of Non-Surgical Periodontal Treatment on Clinical Response, Serum Inflammatory Parameters, and Metabolic Control of Type 2 Diabetes Patients with Moderate to Severe Periodontitis].

Clinical observation of "DM120 Decoction" for type 2 diabetes mellitus: A report of 30 cases

Preliminary Study on Effects in Elasticity of Anterior Tibial Artery in New Patients with Type 2 Diabetes Caused by Medicines of Reducing Blood Sugar

Gliquidone Versus Metformin: Differential Effects on Aorta in Streptozotocin Induced Diabetic Rats

Effects of antiplatelet agents on platelet function with arteriosclerosis obliterans patients of type 2 diabetes mellitus

Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis

Modifying Effect of Diabetes on the Short-Term Effect of Clopidogrel in Patients with Myocardial Infarction

Effects of Glargine on the Levels of Malondialdehyde and Hs-Crp in Type 2 Diabetic Patients

Long-term Effect of Clopidogrel in Patients with and Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of glucose control on the levels of C reactive protein and interleukin-6 in patients with newly onset type 2 diabetics

Effects of Liu wei di huang pills on the vascular endothelial function in type 2 diabetes mellitus

The Effects of Acarbose on Serum Endothelin, C-reactive Protein and Fibrinogen in Impaired Glucose Tolerance Patients

Treatment Outcomes of Clopidogrel in Patients with ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database.

Determination of Vasculopathy-Related Indexes in Patients with Type 2 Diabetes Mellitus and Its Clinical Significance

The Effect of Therapy with Glargine on Glucolipid Metabolism and Insulin Detection in Newly Diagnosed Type 2 Diabetic Patients

Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy

Long-term effect of triple antiplatelet therapy for diabetic patients after percutaneous coronary intervention

Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention